Group One Trading, L.P. Adaptimmune Therapeutics PLC Transaction History

Group One Trading, L.P.

$2.4 Billion
Q3 2024

A detailed history of Group One Trading, L.P. transactions in Adaptimmune Therapeutics PLC stock. As of the latest transaction made, Group One Trading, L.P. holds 48,370 shares of ADAP stock, worth $28,538. This represents 0.0% of its overall portfolio holdings.

Number of Shares

48,370

Previous 34,037 42.11%

Holding current value

$28,538

Previous $33,000 36.36%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$0.92 - $1.39 $13,186 - $19,922	14,333 Added 42.11%	48,370 $45,000
Q2 2024 Aug 14, 2024	BUY	$0.83 - $1.47 $9,686 - $17,154	11,670 Added 52.18%	34,037 $33,000
Q1 2024 May 10, 2024	BUY	$0.7 - $1.75 $15,621 - $39,053	22,316 Added 43756.86%	22,367 $35,000
Q4 2023 Feb 14, 2024	BUY	$0.43 - $0.79 $21 - $40	51 New	51 $0
Q1 2023 May 12, 2023	SELL	$1.06 - $2.16 $2,640 - $5,380	-2,491 Reduced 13.09%	16,541 $18,000
Q4 2022 Feb 09, 2023	SELL	$1.05 - $2.53 $2,100 - $5,060	-2,000 Reduced 9.51%	19,032 $27,000
Q3 2022 Nov 09, 2022	BUY	$1.06 - $2.41 $2,120 - $4,820	2,000 Added 10.51%	21,032 $23,000
Q2 2022 Aug 11, 2022	SELL	$1.33 - $2.28 $4,256 - $7,295	-3,200 Reduced 14.39%	19,032 $32,000
Q1 2022 May 12, 2022	BUY	$1.73 - $4.06 $563 - $1,323	326 Added 1.49%	22,232 $46,000
Q4 2021 Feb 11, 2022	BUY	$3.5 - $5.68 $52,962 - $85,949	15,132 Added 223.38%	21,906 $82,000
Q3 2021 Nov 12, 2021	SELL	$3.44 - $6.37 $154,645 - $286,363	-44,955 Reduced 86.9%	6,774 $35,000
Q2 2021 Aug 10, 2021	BUY	$3.86 - $5.78 $137,693 - $206,184	35,672 Added 222.16%	51,729 $220,000
Q1 2021 May 12, 2021	BUY	$4.9 - $6.83 $76,258 - $106,295	15,563 Added 3150.4%	16,057 $85,000
Q4 2020 Feb 10, 2021	SELL	$4.0 - $9.2 $484 - $1,113	-121 Reduced 19.67%	494 $3,000
Q3 2020 Nov 12, 2020	SELL	$7.66 - $10.78 $214,525 - $301,904	-28,006 Reduced 97.85%	615 $5,000
Q2 2020 Aug 13, 2020	BUY	$2.58 - $12.1 $73,842 - $346,314	28,621 New	28,621 $287,000
Q2 2019 Aug 09, 2019	SELL	$3.23 - $5.41 $21,456 - $35,938	-6,643 Closed	0 $0
Q1 2019 May 13, 2019	SELL	$3.63 - $6.06 $46,761 - $78,064	-12,882 Reduced 65.98%	6,643 $29,000
Q4 2018 Feb 06, 2019	BUY	$3.76 - $14.16 $35,896 - $135,185	9,547 Added 95.68%	19,525 $112,000
Q3 2018 Nov 08, 2018	BUY	$8.27 - $13.56 $59,701 - $97,889	7,219 Added 261.65%	9,978 $135,000
Q2 2018 Aug 14, 2018	BUY	$10.42 - $13.74 $28,748 - $37,908	2,759 New	2,759 $33,000
Q1 2018 May 11, 2018	SELL	$7.1 - $11.56 $1,420 - $2,312	-200 Closed	0 $0
Q3 2017 Nov 15, 2017	BUY	$4.93 - $8.93 $986 - $1,786	200	200 $2,000

Others Institutions Holding ADAP

# of Institutions

Shares Held

150M

Call Options Held

60.8K

Put Options Held

5.8K

View Full List

About Adaptimmune Therapeutics PLC

Ticker ADAP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 163,370,000
Market Cap $96.4M
Description
Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company's specific peptide enhanced affinity receptor (SPEAR) T-cell platform enables it to identify cancer targets. It is developing ADP-A2M4...

More about ADAP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Account

Group One Trading, L.P. Adaptimmune Therapeutics PLC Transaction History